Khan Suliman, Zhang De-Yu, Zhang Ji-Yu, Hayat Mian Khizar, Ren Jingli, Nasir Safyan, Fawad Muhammad, Bai Qian
Department of Cerebrovascular Diseases, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Department of Gastroenterology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Oncol. 2022 Jul 18;12:950374. doi: 10.3389/fonc.2022.950374. eCollection 2022.
Hepatocellular carcinoma (HCC) is the main type of primary liver malignancy and the fourth leading cause of cancer-related death worldwide. MicroRNAs (miRNAs), a type of non-coding RNA that regulates gene expression mainly on post-transcriptional level has a confirmed and important role in numerous biological process. By regulating specific target genes, miRNA can act as oncogene or tumor suppressor. Recent evidence has indicated that the deregulation of miR-NAs is closely associated with the clinical pathological features of HCC. However, the precise regulatory mechanism of each miRNA and its targets in HCC has yet to be illuminated. This study demonstrates that both oncogenic and tumor suppressive miRNAs are crucial in the formation and development of HCC. miRNAs influence biological behavior including proliferation, invasion, metastasis and apoptosis by targeting critical genes. Here, we summarize current knowledge about the expression profile and function of miRNAs in HCC and discuss the potential for miRNA-based therapy for HCC.
肝细胞癌(HCC)是原发性肝脏恶性肿瘤的主要类型,也是全球癌症相关死亡的第四大主要原因。微小RNA(miRNA)是一类主要在转录后水平调节基因表达的非编码RNA,在众多生物学过程中具有已被证实的重要作用。通过调节特定靶基因,miRNA可作为癌基因或肿瘤抑制因子。最近的证据表明,miRNA的失调与HCC的临床病理特征密切相关。然而,每种miRNA及其在HCC中的靶标的精确调控机制尚待阐明。本研究表明,致癌和抑癌miRNA在HCC的形成和发展中都至关重要。miRNA通过靶向关键基因影响包括增殖、侵袭、转移和凋亡在内的生物学行为。在此,我们总结了目前关于miRNA在HCC中的表达谱和功能的知识,并讨论了基于miRNA的HCC治疗的潜力。